scispace - formally typeset
M

Mark A. Feitelson

Researcher at Temple University

Publications -  102
Citations -  5678

Mark A. Feitelson is an academic researcher from Temple University. The author has contributed to research in topics: Hepatitis B virus & Virus. The author has an hindex of 38, co-authored 100 publications receiving 5146 citations. Previous affiliations of Mark A. Feitelson include Second Military Medical University & Thomas Jefferson University.

Papers
More filters
Journal ArticleDOI

Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma

TL;DR: In this paper, a review outlines pathogenic mechanisms that seem to be common to both hepatitis B virus and hepatitis C virus and suggest innovative approaches to the prevention and treatment of HCC.
Journal ArticleDOI

Human viral oncogenesis: a cancer hallmarks analysis.

TL;DR: The Hallmarks of Cancer framework of Hanahan and Weinberg (2000 and 2011) is used to dissect the viral, host, and environmental cofactors that contribute to the biology of multistep oncogenesis mediated by established human oncoviruses.
Journal ArticleDOI

Sustained proliferation in cancer: Mechanisms and novel therapeutic targets

TL;DR: Natural compounds found to inhibit one or more pathways that contribute to proliferation have been found and will be very important for identifying signaling pathways and molecular targets that may provide early diagnostic markers and/or critical targets for the development of new drugs or drug combinations that block tumor formation and progression.
Journal ArticleDOI

Genetic mechanisms of hepatocarcinogenesis.

TL;DR: The observations suggest that there are multiple, perhaps redundant negative growth regulatory pathways that protect cells against transformation and may provide new markers for tumor staging, for assessment of the relative risk of tumor formation, and open new opportunities for therapeutic intervention.
Journal Article

Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma

TL;DR: It is suggested that HBxAg binds to p53 and that this association is important to the development of PHC.